Evotec and Apeiron Biologics to Discover Novel Pain Therapeutics

17-Feb-2006 - Evotec AG and Apeiron Biologics GmbH announced that they have entered into a discovery collaboration to develop small molecules targeting a novel therapeutic concept for pain relief. This concept is based on research activities of Prof Josef Penninger, Director of the Institute for Molecular ...

Fisher Biosciences unit, Cellomics, and Evotec Technologies Sign License Agreement

Companies to collaborate on cell-biology solutions for life-science markets

01-Feb-2006 - Cellomics, Inc., a business unit within the Fisher Biosciences group, and Evotec Technologies GmbH announced that they have entered into a worldwide, non-exclusive patent license agreement. The agreement will provide Evotec Technologies with Cellomics' core High Content Screening (HCS) patent ...

Evotec and Boehringer Ingelheim Significantly Expand and Extend their Joint Drug Discovery Collaboration

18-Jan-2006 - Evotec AG announced that effective from 1 January 2006 Evotec and Boehringer Ingelheim GmbH will significantly expand their drug discovery collaboration initiated in September 2004, effectively doubling the already sizeable programme. At the same time, the collaboration that was originally ...

Boehringer Ingelheim Extends Scope of Collaboration with Evotec into Screening Services

New agreements signed with Boehringer Ingelheim Germany and Canada

04-Nov-2005 - Evotec AG announced that Boehringer Ingelheim (Boehringer) has extended the scope of its collaboration with Evotec. In addition to the substantial discovery programme to jointly identify and develop therapeutics acting on G-Protein Coupled Receptors (GPCRs) Boehringer research sites in Biberach ...

Evotec Technologies and Genedata Enter into Co-marketing Agreement to Offer Turn Key Solutions for Lead Discovery

16-Sep-2005 - Evotec Technologies GmbH and Genedata AG announced that they entered into an agreement to combine their strengths in the area of High Content and High Throughput Screening. Evotec Technologies and Genedata expect synergistic effects in combining Evotec Technologies' instrumentation (EVOscreen® ...

ProPharma Integrated into Evotec Services Division

13-Sep-2005 - Evotec AG announced that ProPharma Limited, its formulation subsidiary based in Glasgow, Scotland, will do business under the Evotec brand from the 1st of September 2005. ProPharma will be integrated into the Evotec Services Division over the coming months. Evotec has been the majority ...

Erste bedeutende Lieferung nach Singapur: Evotec Technologies liefert Forschungsgerät Insight(TM) Cell aus

05-Sep-2005 - Evotec Technologies GmbH gab die Installation ihres neuartigen Analysegeräts Insight(TM) Cell in Singapurs' Biotechnologie-Komplex, Biopolis, bekannt. Das Gerät hat alle Abnahmetests erfolgreich bestanden. Mit der ersten Installation des Insight(TM) Cell in Singapur sowie der ersten Installation ...

Evotec Enters into Long-Term Focused Library Agreement with Almirall

Value Exceeding EUR 2.5 m over the Two-Year Contract Period

26-Jul-2005 - Evotec AG and Almirall Prodesfarma S.A., the leading Spanish multinational company, announced that they have entered into a two-year library synthesis agreement. Applying leading skills in high-speed parallel synthesis, medicinal and com-putational chemistry Evotec will design and synthesise ...

Procter & Gamble Selects Evotec as Provider of Pharmaceutical Discovery and Chemical Development Services

25-Jul-2005 - Evotec AG and Procter & Gamble Pharmaceuticals, Inc. (P&GP), a subsidiary of The Procter & Gamble Company announced that they have entered into agreements whereby Evotec will provide pharmaceutical discovery and chemical development services to P&GP. Under the terms of the agreements, P&GP will ...

Evotec Names Dr Tim Tasker Executive Vice President Clinical Development and Member of the Executive Committee

07-Jul-2005 - Evotec AG announced the appointment of Dr Tim Tasker as Executive Vice President Clinical Development and a member of its Executive Committee. He will lead Evotec's clinical development activities. Evotec has created this position following the acquisition of Evotec Neurosciences and the ...